Division of Nephrology, Department of Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Department of Medicine, Fu Jen Catholic University School of Medicine, New Taipei City, Taiwan.
Med Sci Monit. 2023 Aug 1;29:e940959. doi: 10.12659/MSM.940959.
BACKGROUND Hyperparathyroidism poses significant risks for patients prior to kidney transplantation. However, the outcomes of patients who undergo parathyroidectomy before renal transplantation compared to those without such a procedure remain uncertain. This real-world data study aimed to examine the clinical outcomes of both patient groups. MATERIAL AND METHODS Using the Taiwan National Health Insurance Research Database, we conducted a retrospective cohort study on patients who underwent renal transplantation between January 2005 and December 2015. The patients were divided into two groups: a case group (n=294) with parathyroidectomy and a control group (n=588) without the need for parathyroidectomy before kidney transplantation. The groups were matched based on age, sex, dialysis vintage, and baseline characteristics at a 1:2 ratio. Hazard ratios (HR) were estimated using the Cox regression model. The main outcomes assessed were graft failure, mortality, and major adverse cardiovascular events (MACE) recorded until December 2019. RESULTS During a mean follow-up period of 6 years, a significant difference was observed in graft failure (HR 1.40; 95% confidence interval 1.10-1.79, p=0.007) between the two groups. After further adjustment, graft failure remained significant (HR 1.52; 95% CI 1.07-2.15, p=0.019). Additionally, machine learning-based feature selection identified the importance of parathyroidectomy (ranked 9 out of 11) before kidney transplantation in predicting subsequent graft failure. CONCLUSIONS Our study demonstrates that severe hyperparathyroidism requiring parathyroidectomy before kidney transplantation may contribute to poor post-transplant graft outcomes compared to patients who do not require parathyroidectomy.
甲状旁腺功能亢进症在肾移植前对患者存在重大风险。然而,甲状旁腺切除术在肾移植前与不进行该手术的患者相比,其临床结局尚不确定。本真实世界数据研究旨在评估这两组患者的临床结局。
我们使用台湾全民健康保险研究数据库,对 2005 年 1 月至 2015 年 12 月期间接受肾移植的患者进行了回顾性队列研究。患者分为两组:甲状旁腺切除术组(n=294)和未行甲状旁腺切除术的对照组(n=588)。两组患者按年龄、性别、透析龄和基线特征以 1:2 的比例进行匹配。采用 Cox 回归模型估计风险比(HR)。主要结局评估包括移植失败、死亡率和截至 2019 年 12 月记录的主要不良心血管事件(MACE)。
在平均 6 年的随访期间,两组患者在移植失败方面存在显著差异(HR 1.40;95%置信区间 1.10-1.79,p=0.007)。进一步调整后,移植失败仍然显著(HR 1.52;95%CI 1.07-2.15,p=0.019)。此外,基于机器学习的特征选择确定了甲状旁腺切除术(在 11 个特征中排名第 9)在预测随后移植失败方面的重要性。
本研究表明,与不需要甲状旁腺切除术的患者相比,严重甲状旁腺功能亢进症需要在肾移植前进行甲状旁腺切除术可能导致移植后不良的移植结局。